The lastest financing round was in March 2021. LinkDoc, as the first unicorn in the area of medical AI and big data, has finalized six rounds of financing backed by leading medical industry investors including Alibaba Health Information Technology Ltd (0241: HK), Temasek and Lake Bleu Prime Healthcare Master Fund since its establishment in 2014. However, loss widened in the first quarter of 2021 to CNY 80 million from 56 million in 2020. The corresponding net operating loss was CNY 138 million in 2021, an increase of 116% from CNY 64.15 million in 2020.įrom 2019 to 2020, the adjusted net loss narrowed to CNY 232 million from CNY 389 million. In the first quarter of 2021, the operating loss was CNY 90.216 million compared with CNY 59.08 million during the same period in 2020. Three other Chinese companies with pending U.S. IPO, nine months after its 11th hour halt to the listing. Sources told Reuters that LinkDoc was in the midst of filing for a 211 million initial public offering (IPO) in New York but scrapped the plans after Beijing pulled Didi from app stores and from. The corresponding net operating loss was CNY 434 million and CNY 488 million. LinkDoc has formally withdrawn its plan to raise 200 million from a U.S. LinkDoc recorded an operating loss of CNY 408 million and CNY 250 million in 20 respectively. In the first quarter of 2021, they took a combined 80.2% of the total revenue, 6.8% lower than a year earlier About 75% and 85.5% of the total revenue in 20 was from them. The prospectus also showed that most of the earnings came from the sales of medicines and health care products. In the first quarter of 2021, LinkDoc generated CNY 223 million in revenue, compared to CNY 159 million in the same period in 2020. It is said that LinkDoc shelved the plan due to toughened Chinese cybersecurity regulations on overseas-listed companies.Īccordig to its latest prospectus, LinkDoc’s revenue rose to CNY 941.6 million (USD 148 million) in 2020 from CNY 4.99 billion in 2019, up 89% year on year. However, it called off the process on July 9. Medical data group LinkDoc Technology Ltd in July became the first Chinese company to shelve plans for an IPO in the United States due to Beijing's clampdown on overseas listings by. LinkDoc's decision to suspend its 211 million IPO, first reported by Reuters, is likely to be followed by others, analysts said, although they noted that U.S. On July 1, 2021, LinkDoc updated its IPO prospectus after it was first filed in June of the same year. Backed by Alibaba Health Information Technology, LinkDoc filed for its IPO last month and was due to price its shares after the US market close on Thursday. LinkDoc Technology recently withdrew its IPO application in the US market after a nine-month halt to the process.
0 kommentar(er)
